High Vista Strategies LLC Celldex Therapeutics, Inc. Transaction History

High Vista Strategies LLC

$255 Million
Q3 2024

A detailed history of High Vista Strategies LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 8,981 shares of CLDX stock, worth $233,865. This represents 0.12% of its overall portfolio holdings.

Number of Shares

8,981

Previous 9,627 6.71%

Holding current value

$233,865

Previous $356,000 14.33%

% of portfolio

0.12%

Previous 0.14%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.06 - $44.56 $20,710 - $28,785	-646 Reduced 6.71%	8,981 $305,000
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $315,380 - $409,725	9,627 New	9,627 $356,000
Q3 2023 Nov 14, 2023	SELL	$25.45 - $37.46 $184,767 - $271,959	-7,260 Reduced 29.34%	17,482 $481,000
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $19,001 - $31,039	-684 Reduced 2.69%	24,742 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $68,417 - $113,235	3,014 Added 13.45%	25,426 $715,000
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $68,183 - $124,159	-3,326 Reduced 12.92%	22,412 $604,000
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $113,821 - $161,919	-4,118 Reduced 13.79%	25,738 $877,000
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $49,595 - $78,215	1,390 Added 4.88%	29,856 $1.15 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $157,111 - $303,857	-5,427 Reduced 16.01%	28,466 $1.54 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $19,736 - $33,707	953 Added 2.89%	33,893 $1.13 Million
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $273,853 - $505,927	-16,915 Reduced 33.93%	32,940 $678,000
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $75,339 - $114,341	5,026 Added 11.21%	49,855 $873,000
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $432,599 - $680,952	44,829 New	44,829 $665,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Account

High Vista Strategies LLC Celldex Therapeutics, Inc. Transaction History